Jessica M. Haverkamp, Ph.D. - Publications
Affiliations: | 2011 | Immunology | University of Iowa, Iowa City, IA |
Area:
ImmunologyYear | Citation | Score | |||
---|---|---|---|---|---|
2022 | Calvert RD, Fleet JC, Fournier PGJ, Juarez P, Burcham GN, Haverkamp JM, Guise TA, Ratliff TL, Elzey BD. Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity. Immunohorizons. 6: 790-806. PMID 36480485 DOI: 10.4049/immunohorizons.2200079 | 0.373 | |||
2011 | Svensson RU, Haverkamp JM, Thedens DR, Cohen MB, Ratliff TL, Henry MD. Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer. The American Journal of Pathology. 179: 502-12. PMID 21703427 DOI: 10.1016/J.Ajpath.2011.03.014 | 0.733 | |||
2011 | Haverkamp JM, Charbonneau B, Crist SA, Meyerholz DK, Cohen MB, Snyder PW, Svensson RU, Henry MD, Wang HH, Ratliff TL. An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate. The Prostate. 71: 1139-50. PMID 21656824 DOI: 10.1002/Pros.21327 | 0.584 | |||
2011 | Haverkamp JM, Crist SA, Elzey BD, Cimen C, Ratliff TL. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. European Journal of Immunology. 41: 749-59. PMID 21287554 DOI: 10.1002/Eji.201041069 | 0.606 | |||
2008 | Haverkamp J, Charbonneau B, Ratliff TL. Prostate inflammation and its potential impact on prostate cancer: a current review. Journal of Cellular Biochemistry. 103: 1344-53. PMID 17955503 DOI: 10.1002/Jcb.21536 | 0.586 | |||
Show low-probability matches. |